Implementation of a whole blood programme within a blood service: Practical guidance for blood providers
Vox Sanguinis · 2026
DOI: 10.1111/vox.70168 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vox Sanguinis, 2026. Verfasst von Torunn Oveland Apelseth und 11 weiteren Autor:innen. Beteiligte Einrichtung: Norwegian Center for Blood Preparedness, Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Blood Transfusion, Hemorrhage. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives Early balanced transfusion is recommended for resuscitation of patients with severe bleeding. Whole blood (WB) is reintroduced as a feasible alternative to blood components, as it includes red blood cells, plasma and platelets in a physiological ratio. Materials and Methods In this review, we aim to provide practical guidance and a framework for blood providers aiming to implement a WB programme. The review summarizes recommendations and practical implications identified from published literature, regulatory requirements and current programmes.
Results
WB donors are selected based on national donor selection criteria. When the patients' ABO‐type is unknown, low titre anti‐A and anti‐B group‐O WB (LTOWB) are recommended. ABO‐group type‐specific blood can be used in patients with known ABO type. Anticoagulants include CPD and CPDA‐1. Leukoreduction can be performed with a platelet‐sparing filter. WB is stored at +2 to –6°C for up to 35 days. Rotation of the stock and re‐manufacturing to red cell concentrates minimizes outdating. The EDQM Guide to the preparation, use and quality assurance of blood components provides the minimum requirements. Post‐implementation follow‐up includes haemovigilance and quality surveillance. End users should be involved in the development of the programme and training of personnel. Emergency collection of WB can enable transfusion to patients in remote areas, during disasters and during war.
Conclusion
We conclude that implementation of a WB programme for routine and emergency management of patients with severe bleeding can be performed in a structured, safe and sustainable way.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Norwegian Center for Blood Preparedness, Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.
- Faculty of Medicine, University of Bergen, Bergen, Norway.
- The Blood Bank, Landspitali University Hospital, Reykjavik, Iceland.
- Reykjavik University, Reykjavik, Iceland.
- Irish Blood Transfusion Service, Dublin, Republic of Ireland.
- Scottish National Blood Transfusion Service, Edinburgh, Scotland.
ORCID-Profile: Torunn Oveland Apelseth, Thomas Klei
Zitieren
APA
Apelseth, T. O., Sigurjónsson, Ó. E., Doyle, B., Evans, R., George, C., Handke, W., Humbrecht, C., Najdovski, T., O'Leary, P., Wiltshire, M., Klei, T., & European Blood Alliance Working Group on Innovations and New Products (2026). Implementation of a whole blood programme within a blood service: Practical guidance for blood providers. Vox Sanguinis. https://doi.org/10.1111/vox.70168
Vancouver
Apelseth TO, Sigurjónsson ÓE, Doyle B, Evans R, George C, Handke W, et al. Implementation of a whole blood programme within a blood service: Practical guidance for blood providers. Vox Sanguinis. 2026. doi:10.1111/vox.70168
BibTeX
@article{Apelseth2026,
author = {Apelseth, Torunn Oveland and Sigurjónsson, Ólafur Eysteinn and Doyle, Barry and Evans, Ryan and George, Chloe and Handke, Wiebke and Humbrecht, Catherine and Najdovski, Tome and O'Leary, Peter and Wiltshire, Michael and Klei, Thomas and European Blood Alliance Working Group on Innovations and New Products, European Blood Alliance Working Group on Innovations and New Products},
title = {Implementation of a whole blood programme within a blood service: Practical guidance for blood providers},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70168}
}
EUVIMED